Sell Sun Pharma on bounce, says Hemen Kapadia

Hemen Kapadia of KRChoksey Securities told CNBC-TV18, "Sun Pharmaceutical is or was in an uptrend for the last 18 years, Rs 800 was very crucial long-term support, we have broken that. It probably gave a bounce back and recovered but sustainability at higher levels now seems suspect.""After a long time we have seen some technical weakness in Sun Pharma. So I would suggest sell on bounce because first in 18 years, I am seeing technical heaviness. It might go away, it might not go away but to play it safe, I would suggest to sell on bounce," he added.